There were 86% fewer total deaths in 14 months in statin users given extended-release niacin compared to those given Zetia (ezetimibe) according to a study published in the New England Journal of Medicine. There was one (1) deaths in the niacin group during the 14 months versus seven (7) deaths in the Zetia (ezetimibe) group. Two of the deaths in the Zetia (ezetimibe) group, and one (1) death in the niacin group were non-cardiovascular, however, they don’t say what they were. Since statins and other cholesterol-lowering drugs which artificially lower cholesterol have been found to increase the risk of cancer, suicide, accidental death, and congestive heart failure (with statins), these two deaths may or may not be relevant. Since they did not say what these people died from, it feels to me like they are trying to hide something. I am trying to find out what these other people died from.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.